Literature DB >> 22457005

TLR3-mediated apoptosis and activation of phosphorylated Akt in the salivary gland epithelial cells of primary Sjögren's syndrome patients.

Hideki Nakamura1, Yoshiro Horai, Takahisa Suzuki, Akitomo Okada, Kunihiro Ichinose, Satoshi Yamasaki, Takehiko Koji, Atsushi Kawakami.   

Abstract

This study aimed at ascertain whether innate immunity is involved in the apoptosis of primary cultured salivary gland epithelial cells (SGECs) in primary Sjögren's syndrome (pSS). Induction of apoptosis of SGECs was performed using a TLR3 ligand, poly (I:C). Activation of phosphorylated-Akt (pAkt) and cleaved-caspase 3 was determined by Western blotting or immunofluorescence. Expression of TLR2 and TLR3 with pAkt was observed in cultured SGECs after 24-h stimulation with each ligand. Compared with stimulation with the peptidoglycan or lipopolysaccharide, that with poly (I:C) induced significant nuclear fragmentation, as determined by Hoechst staining (p = 0.0098). Apoptosis was confirmed by terminal deoxynucleotidyltransferase-mediated dUTP nick end-labeling (TUNEL) staining of SGECs from pSS patients and a normal subject. A significant increase in TUNEL-positive cells was observed by the addition of a PI3K inhibitor, LY294002. Poly (I:C) phosphorylated stress-activated protein kinase/Jun-terminal kinase and p44/42 MAP kinase as well as Akt. Furthermore, poly (I:C)-induced caspase 3 cleavage in SGECs was also inhibited by LY294002. Similar results were obtained using SGECs obtained from a normal subject. The results demonstrated for the first time that TLR3 induces the apoptotic cell death of SGECs via the PI3K-Akt signaling pathway.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22457005     DOI: 10.1007/s00296-012-2381-9

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   2.631


  28 in total

Review 1.  Classification criteria for Sjögren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group.

Authors:  C Vitali; S Bombardieri; R Jonsson; H M Moutsopoulos; E L Alexander; S E Carsons; T E Daniels; P C Fox; R I Fox; S S Kassan; S R Pillemer; N Talal; M H Weisman
Journal:  Ann Rheum Dis       Date:  2002-06       Impact factor: 19.103

Review 2.  The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors.

Authors:  Taro Kawai; Shizuo Akira
Journal:  Nat Immunol       Date:  2010-04-20       Impact factor: 25.606

3.  A single centre retrospective analysis of AECG classification criteria for primary Sjogren's syndrome based on 112 minor salivary gland biopsies in a Japanese population.

Authors:  Hideki Nakamura; Atsushi Kawakami; Naoki Iwamoto; Akitomo Okada; Satoshi Yamasaki; Mami Tamai; Hiroaki Ida; Yukinori Takagi; Tomayoshi Hayashi; Kiyoshi Aoyagi; Takashi Nakamura; Katsumi Eguchi
Journal:  Rheumatology (Oxford)       Date:  2010-03-24       Impact factor: 7.580

4.  Salivary epithelial cells from Sjogren's syndrome patients are highly sensitive to anoikis induced by TLR-3 ligation.

Authors:  Menelaos N Manoussakis; Maria P Spachidou; Christos I Maratheftis
Journal:  J Autoimmun       Date:  2010-08-03       Impact factor: 7.094

5.  TLR3 signaling in a hepatoma cell line is skewed towards apoptosis.

Authors:  Elina Khvalevsky; Ludmila Rivkin; Jacob Rachmilewitz; Eithan Galun; Hilla Giladi
Journal:  J Cell Biochem       Date:  2007-04-01       Impact factor: 4.429

Review 6.  Sjögren's syndrome.

Authors:  Robert I Fox
Journal:  Lancet       Date:  2005 Jul 23-29       Impact factor: 79.321

7.  Anti-centromere antibody-seropositive Sjögren's syndrome differs from conventional subgroup in clinical and pathological study.

Authors:  Hideki Nakamura; Atsushi Kawakami; Tomayoshi Hayashi; Naoki Iwamoto; Akitomo Okada; Mami Tamai; Satoshi Yamasaki; Hiroaki Ida; Katsumi Eguchi
Journal:  BMC Musculoskelet Disord       Date:  2010-07-01       Impact factor: 2.362

8.  Rapid and significant induction of TRAIL-mediated type II cells in apoptosis of primary salivary epithelial cells in primary Sjögren's syndrome.

Authors:  Hideki Nakamura; Atsushi Kawakami; Naoki Iwamoto; Hiroaki Ida; Takehiko Koji; Katsumi Eguchi
Journal:  Apoptosis       Date:  2008-11       Impact factor: 4.677

9.  Epidermal growth factor inhibits Fas-mediated apoptosis in salivary epithelial cells of patients with primary Sjögren's syndrome.

Authors:  H Nakamura; A Kawakami; H Ida; T Koji; K Eguchi
Journal:  Clin Exp Rheumatol       Date:  2007 Nov-Dec       Impact factor: 4.473

10.  RIP1 is an essential mediator of Toll-like receptor 3-induced NF-kappa B activation.

Authors:  Etienne Meylan; Kim Burns; Kay Hofmann; Vincent Blancheteau; Fabio Martinon; Michelle Kelliher; Jürg Tschopp
Journal:  Nat Immunol       Date:  2004-04-04       Impact factor: 25.606

View more
  12 in total

Review 1.  Innate immunity in Sjögren's syndrome.

Authors:  Jeremy Kiripolsky; Liam G McCabe; Jill M Kramer
Journal:  Clin Immunol       Date:  2017-04-08       Impact factor: 3.969

Review 2.  Contributions of Major Cell Populations to Sjögren's Syndrome.

Authors:  Richard Witas; Shivai Gupta; Cuong Q Nguyen
Journal:  J Clin Med       Date:  2020-09-22       Impact factor: 4.241

3.  Innate Immune Signaling Induces IL-7 Production, Early Inflammatory Responses, and Sjögren's-Like Dacryoadenitis in C57BL/6 Mice.

Authors:  Jing Zhou; Jun-O Jin; Juan Du; Qing Yu
Journal:  Invest Ophthalmol Vis Sci       Date:  2015-12       Impact factor: 4.799

4.  Immune complexome analysis reveals the presence of immune complexes and identifies disease-specific immune complex antigens in saliva samples from patients with Sjögren's syndrome.

Authors:  K Yamane; H Nakamura; M Hamasaki; Y Minei; N Aibara; T Shimizu; A Kawakami; M Nakashima; N Kuroda; K Ohyama
Journal:  Clin Exp Immunol       Date:  2021-02-22       Impact factor: 4.330

Review 5.  Reviewing primary Sjögren's syndrome: beyond the dryness - From pathophysiology to diagnosis and treatment.

Authors:  Tim Both; Virgil A S H Dalm; P Martin van Hagen; Paul L A van Daele
Journal:  Int J Med Sci       Date:  2017-02-23       Impact factor: 3.738

Review 6.  Current and Emerging Evidence for Toll-Like Receptor Activation in Sjögren's Syndrome.

Authors:  Jeremy Kiripolsky; Jill M Kramer
Journal:  J Immunol Res       Date:  2018-12-20       Impact factor: 4.818

7.  Activation of Myd88-Dependent TLRs Mediates Local and Systemic Inflammation in a Mouse Model of Primary Sjögren's Syndrome.

Authors:  Jeremy Kiripolsky; Rose-Anne Romano; Eileen M Kasperek; Guan Yu; Jill M Kramer
Journal:  Front Immunol       Date:  2020-01-09       Impact factor: 7.561

8.  Innate immunity activation involved in unprotected porcine auto-transplant kidneys preserved by naked caspase-3 siRNA.

Authors:  Cheng Yang; Long Li; Yinjia Xue; Zitong Zhao; Tian Zhao; Yichen Jia; Ruiming Rong; Ming Xu; Michael L Nicholson; Tongyu Zhu; Bin Yang
Journal:  J Transl Med       Date:  2013-09-13       Impact factor: 5.531

9.  Leptin/OB-R pathway promotes IL-4 secretion from B lymphocytes and induces salivary gland epithelial cell apoptosis in Sjögren's syndrome.

Authors:  Ting Xu; Wen Xie; Yingchun Ma; Shiliang Zhou; Lu Zhang; Jinyun Chen; Mingyuan Cai; Rurong Sun; Peirong Zhang; Shaobo Yu; Zheng Xu; Wanlan Jiang; Min Wu
Journal:  Oncotarget       Date:  2017-06-28

Review 10.  Modulation of Apoptosis by Cytotoxic Mediators and Cell-Survival Molecules in Sjögren's Syndrome.

Authors:  Hideki Nakamura; Yoshiro Horai; Toshimasa Shimizu; Atsushi Kawakami
Journal:  Int J Mol Sci       Date:  2018-08-11       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.